BioRestorative Therapies, Inc. (BRTX)
1.54
+0.08
(+5.48%)
USD |
NASDAQ |
Oct 16, 13:06
BioRestorative Therapies SG&A Expense (TTM) : 5.181M for March 31, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.181M |
| December 31, 2025 | 6.821M |
| September 30, 2025 | 6.677M |
| June 30, 2025 | 6.744M |
| March 31, 2025 | 6.629M |
| December 31, 2024 | 6.600M |
| September 30, 2024 | 8.087M |
| June 30, 2024 | 9.23M |
| March 31, 2024 | 10.25M |
| December 31, 2023 | 11.74M |
| September 30, 2023 | 13.19M |
| June 30, 2023 | 14.52M |
| March 31, 2023 | 15.83M |
| December 31, 2022 | 15.46M |
| September 30, 2022 | 15.23M |
| June 30, 2022 | 15.04M |
| March 31, 2022 | 14.86M |
| December 31, 2021 | 25.55M |
| September 30, 2021 | 22.42M |
| June 30, 2021 | 19.30M |
| March 31, 2021 | 16.08M |
| December 31, 2020 | 1.808M |
| September 30, 2020 | 2.518M |
| June 30, 2020 | 3.250M |
| March 31, 2020 | 4.249M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.927M |
| September 30, 2019 | 4.789M |
| June 30, 2019 | 4.155M |
| March 31, 2019 | 4.268M |
| December 31, 2018 | 4.375M |
| September 30, 2018 | 4.040M |
| June 30, 2018 | 4.346M |
| March 31, 2018 | 4.152M |
| December 31, 2017 | 3.969M |
| September 30, 2017 | 3.866M |
| June 30, 2017 | 3.748M |
| March 31, 2017 | 3.645M |
| December 31, 2016 | 3.344M |
| September 30, 2016 | 4.515M |
| June 30, 2016 | 4.526M |
| March 31, 2016 | 4.270M |
| December 31, 2015 | 4.308M |
| September 30, 2015 | 2.952M |
| June 30, 2015 | 2.860M |
| March 31, 2015 | 2.679M |
| December 31, 2014 | 2.384M |
| September 30, 2014 | 2.581M |
| June 30, 2014 | 2.750M |
| March 31, 2014 | 2.927M |
| December 31, 2013 | 3.160M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Myriad Genetics, Inc. | 539.90M |
| CareDx, Inc. | 247.69M |
| Natera, Inc. | 1.255B |
| Exagen, Inc. | 48.45M |
| Sera Prognostics, Inc. | 24.17M |